Current List Prices
Wegovy and Ozempic, both from Novo Nordisk, have similar per-unit pricing but differ due to dosing. A Wegovy 2.4 mg maintenance pen (weekly dose) lists at about $1,350 per month. Ozempic's 2 mg pen (highest dose, weekly) lists at roughly $1,000-$1,100 monthly. Off-label Ozempic use for weight loss often matches Wegovy's dose, making effective monthly costs comparable at list price—around $1,300 for equivalent semaglutide exposure.[1][2]
Insurance Coverage and Patient Costs
Most insurers cover Ozempic for diabetes but restrict Wegovy to obesity, leading to higher out-of-pocket for Wegovy (often $1,000+ monthly without coverage). With coverage, Ozempic copays average $25-$100 monthly via savings cards; Wegovy matches at $0-$25 for eligible patients. Over 12 months, insured Ozempic users pay ~$300-$1,200 total, versus $500-$5,000+ for Wegovy if uncovered.[3]
Price Changes Over Time
Both drugs launched with ~$1,300 monthly list prices in 2017-2021. Ozempic's price rose 3-5% annually through 2023, hitting $936 per box (four 1 mg pens). Wegovy followed suit, up ~4% yearly. Shortages in 2022-2024 drove temporary copay hikes, but Novo capped savings at $225/month initially, expanding to $500+ by 2024. Cumulative 5-year increase: ~25% for both, outpacing inflation.[1][4]
| Year | Ozempic Monthly List (2 mg equiv.) | Wegovy Monthly List (2.4 mg) |
|------|------------------------------------|------------------------------|
| 2020 | ~$1,000 | N/A (launched 2021) |
| 2022 | ~$1,100 | ~$1,350 |
| 2024 | ~$1,150 | ~$1,350 |
Long-Term Cost Trends and Factors
Prices stabilize due to patent protection until 2031-2032 (semaglutide patents expire ~2032; check DrugPatentWatch.com for updates).[5] Biosimilars could cut costs 30-50% post-2032, like Humira's drop. Compounded semaglutide (post-shortage) costs $200-$500/month but faces FDA crackdowns. Over 3 years, total spend: $10,000-$40,000 for Ozempic (insured), $20,000-$50,000+ for Wegovy without aid. Employer plans increasingly cover both equally.[2][6]
[1]: Novo Nordisk pricing (novonordisk-us.com)
[2]: GoodRx average costs (goodrx.com)
[3]: IQVIA claims data 2023
[4]: HHS drug price reports (aspe.hhs.gov)
[5]: DrugPatentWatch.com (drugpatentwatch.com)
[6]: FDA compounding guidance (fda.gov)